Mannon R B, Kotzin B L, Nataraj C, Ferri K, Roper E, Kurlander R J, Coffman T M
Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, and Veterans Administration Medical Center, Durham, North Carolina 27710, USA.
J Clin Invest. 1998 Jun 1;101(11):2517-27. doi: 10.1172/JCI1229.
Allospecific CD8(+) T lymphocytes are an important component of the cellular response in allograft rejection. These cells recognize and engage MHC class I antigens, leading to allospecific cytolytic responses and graft rejection. In mouse kidney allografts that survive to 3 wk after transplantation, we noted that the majority of CD8(+) cells do not express surface alpha/beta T cell receptor alpha/beta(TCR), gamma/deltaTCR, or CD3. However, these CD8(+)TCR- cells did express surface markers characteristic of T cells, including Thy1.2, CD2, and CD5. In addition, the CD8(+)TCR- cells expressed mRNA for TCR Vbeta gene families, and nearly half stained positive for cytoplasmic Vbeta8 protein, suggesting that they are T cells that have downregulated alpha/betaTCR protein expression from their cell surfaces. When these surface TCR- cells were isolated from kidney allografts by flow cytometry and cultured in the presence of either allogeneic or syngeneic stimulators, nearly 100% of cells reacquired normal levels of alpha/betaTCR expression with disproportionate usage of Vbeta8 chains. After recovery of their surface TCR expression, the CD8(+)TCR- population demonstrated strong alloreactivity in culture. These results suggest that the substantial number of CD8(+)TCR- cells found in long-term surviving mouse kidney allografts are alpha/beta-T cells that have downregulated their cell surface expression of TCR. While in other systems this phenotype may identify cells that have engaged antigen, our results indicate that loss of TCR expression by CD8(+) kidney graft-infiltrating cells may not depend on antigen engagement and that elements in the microenvironment of the kidney graft play a key role in this process. Factors that modulate expression of TCR by graft-infiltrating lymphocytes may have an important role in regulating rejection responses.
同种异体特异性CD8(+) T淋巴细胞是同种异体移植排斥反应中细胞应答的重要组成部分。这些细胞识别并结合MHC I类抗原,导致同种异体特异性细胞溶解反应和移植排斥。在移植后存活3周的小鼠肾脏同种异体移植中,我们注意到大多数CD8(+)细胞不表达表面α/β T细胞受体α/β(TCR)、γ/δ TCR或CD3。然而,这些CD8(+)TCR-细胞确实表达了T细胞特有的表面标志物,包括Thy1.2、CD2和CD5。此外,CD8(+)TCR-细胞表达TCR Vβ基因家族的mRNA,近一半细胞胞质Vβ8蛋白染色呈阳性,表明它们是已从细胞表面下调α/β TCR蛋白表达的T细胞。当通过流式细胞术从肾脏同种异体移植中分离出这些表面TCR-细胞,并在同种异体或同基因刺激物存在的情况下进行培养时,近100%的细胞重新获得了正常水平的α/β TCR表达,且Vβ8链的使用不成比例。在恢复其表面TCR表达后,CD8(+)TCR-群体在培养中表现出强烈的同种异体反应性。这些结果表明,在长期存活的小鼠肾脏同种异体移植中发现的大量CD8(+)TCR-细胞是已下调其TCR细胞表面表达的α/β -T细胞。虽然在其他系统中这种表型可能识别已接触抗原的细胞,但我们的结果表明,CD8(+)肾脏移植浸润细胞TCR表达的丧失可能不依赖于抗原接触,并且肾脏移植微环境中的因素在这一过程中起关键作用。调节移植浸润淋巴细胞TCR表达的因素可能在调节排斥反应中起重要作用。